 |
PDBsum entry 3vnt
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3vnt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the kinase domain of human vegfr2 with a [1, 3]thiazolo[5,4-b]pyridine derivative
|
|
Structure:
|
 |
Vascular endothelial growth factor receptor 2. Chain: a. Fragment: unp residues 806-1171. Synonym: vegfr-2, fetal liver kinase 1, flk-1, kinase insert domain receptor, kdr, protein-tyrosine kinase receptor flk-1. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: kdr, flk1, vegfr2. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
|
|
Resolution:
|
 |
|
1.64Å
|
R-factor:
|
0.153
|
R-free:
|
0.192
|
|
|
Authors:
|
 |
H.Oki
|
|
Key ref:
|
 |
M.Okaniwa
et al.
(2012).
Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds.
J Med Chem,
55,
3452-3478.
PubMed id:
|
 |
|
Date:
|
 |
|
17-Jan-12
|
Release date:
|
11-Apr-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P35968
(VGFR2_HUMAN) -
Vascular endothelial growth factor receptor 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1356 a.a.
301 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
55:3452-3478
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds.
|
|
M.Okaniwa,
M.Hirose,
T.Imada,
T.Ohashi,
Y.Hayashi,
T.Miyazaki,
T.Arita,
M.Yabuki,
K.Kakoi,
J.Kato,
T.Takagi,
T.Kawamoto,
S.Yao,
A.Sumita,
S.Tsutsumi,
T.Tottori,
H.Oki,
B.C.Sang,
J.Yano,
K.Aertgeerts,
S.Yoshida,
T.Ishikawa.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |